Prostate Cancer Has 93% Five-Year Survival Rate, Le Progrès Reports
Surviving Prostate Cancer
Prostate cancer achieves a five-year survival rate of 93 percent, according to reporting by Le Progrès.
- Prostate cancer represents one-fifth of all male cancer diagnoses in reporting regions, characterized by high survival rates when detected early.
- Screening methodologies rely primarily on blood marker evaluations and clinical examinations, though regional protocols vary regarding organized screening programs.
- Public health campaigns continue to emphasize regular medical consultations and symptom awareness to overcome the silence surrounding male malignancies.
The statistical landscape of male malignancies reveals significant regional variations across international health registries. In Belgium, 12,535 new prostate cancers were diagnosed in 2024, alongside 474 testicular cancers and 110 penile cancers, according to data reported by DHnet. Meanwhile, the National Cancer Registry in Mauritius recorded 286 new prostate cancer cases in 2025 out of 1,408 total male cancer diagnoses, representing roughly one in five cases, as detailed by lexpress.mu.
That registry also documented 121 deaths from the disease that same year, operating without an organized national screening program. In 2025, 4,756 men underwent screening in the hospital sector using the prostate-specific antigen blood test, and the National Cancer Registry also recorded 14 new diagnoses of testicular cancer that same year, primarily among men aged 30 to 34 years.
Clinical registries highlight an upward trajectory in diagnostic numbers over recent years. Dr. Cynthia Leste Boodoo of the Mauritian National Cancer Registry noted fluctuations alongside a general upward trend, pointing out that new prostate cancer cases rose from 223 in 2021 to 286 in 2025, representing an increase of approximately 28 percent over four years, as reported by lexpress.mu.
In terms of mortality outcomes, the Belgian health figures attributed 1,485 deaths to the disease in 2023, while maintaining a ten-year survival prognosis of 97 percent, per DHnet reporting. The broader health context also encompasses mental health impacts, with Mauritian records noting that 97 of the 112 suicides registered in 2024 involved men, representing nearly nine out of ten cases.
Medical authorities frequently emphasize the silent nature of early-stage disease development. According to insights shared via DHnet, early localized phases typically manifest zero symptoms, requiring vigilance regarding urinary difficulties, increased frequency, or hematuria. Diagnostic pathways in public hospital systems generally require patients to initiate consultations for urinary symptoms, leading to physician evaluations, physical examinations, or digital rectal exams, followed by prostate-specific antigen blood testing upon clinical prescription, as outlined by lexpress.mu.
For individuals seeking confidential guidance, Cancerinfo provides a free support line at 0800 15 801, with coordinator Pierre Coulie noting that a first question can already help take the step
and adding that with Cancerinfo, no one has to remain alone with their worries.
Similarly, support services like Befrienders Mauritius operate a free telephone helpline at 800 93 93, where long-serving volunteer Sheïla Cheekhoory observes that men speak out more readily today, stating that they know we do not judge them.
Technological advancements in surgical treatment continue to evolve within clinical settings. During Movember outreach events in November 2026, medical institutions such as the Pasteur clinic in Royan showcased robotic surgical systems like the Da Vinci X to demonstrate minimally invasive procedures for prostate, kidney, and bladder interventions, according to Sud Ouest reporting. Urologists utilizing these consoles point to enhanced precision and reduced hospital stays compared to traditional open surgical methods.
Dorine Brousse, communications officer for the Vivalto Santé group, explained that the idea is to show what can be done with this technology and to offer an immersive experience by putting oneself in the surgeon’s place.
Dr. Jean-Philippe Le Paih, a urologist at the clinic who trained in robotic surgery during his residency, detailed that the system comprises three main parts: a computer control tower, a patient-side cart featuring four very thin articulated arms holding a high-definition endoscope and miniaturized tools, and a command console positioned a few meters away where surgeons operate via joysticks and foot pedals.
Dr. Arnaud Bracq and his colleagues traveled to Strasbourg four years prior to complete training on the equipment, which Dr. Le Paih noted is used almost daily for major procedures such as partial or total removal of the bladder, a kidney, or the prostate, building on hundreds of patient interventions performed with the technology since 2022.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice.